Bayer AG
XETRA:BAYN
Bayer AG
Free Cash Flow
Bayer AG
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Free Cash Flow
€2.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-2%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Free Cash Flow
$-84.7m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Free Cash Flow
€1.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
|
MPH Health Care AG
XETRA:93M1
|
Free Cash Flow
€12m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Free Cash Flow
€177.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Free Cash Flow
€23.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Free Cash Flow?
Free Cash Flow
2.4B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Free Cash Flow amounts to 2.4B EUR.
What is Bayer AG's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-2%
Over the last year, the Free Cash Flow growth was -43%. The average annual Free Cash Flow growth rates for Bayer AG have been -2% over the past three years , -15% over the past five years , and -2% over the past ten years .